These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1511044)

  • 1. Bicarbonate- versus lactate-based CAPD fluids: a biocompatibility study in rabbits.
    Schambye HT; Flesner P; Pedersen RB; Hardt-Madsen M; Chemnitz J; Christensen HK; Detmer A; Pedersen FB
    Perit Dial Int; 1992; 12(3):281-6. PubMed ID: 1511044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents.
    Schambye HT; Pedersen FB; Wang P
    Adv Perit Dial; 1992; 8():42-6. PubMed ID: 1361838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid-base balance with different CAPD solutions.
    Feriani M; Ronco C; La Greca G
    Perit Dial Int; 1996; 16 Suppl 1():S126-9. PubMed ID: 8728178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
    Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
    Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
    Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
    Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
    Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
    Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
    Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients dialyzed exclusively with lactate-buffered dialysate.
    Daugirdas JT; Gandhi VC; McShane AP; Leehey DJ; Chan AY; Jablokow VR; Ing TS
    Int J Artif Organs; 1986 Nov; 9(6):413-6. PubMed ID: 3818115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of new dialysis solutions on peritonitis rates.
    Ahmad S; Sehmi JS; Ahmad-Zakhi KH; Clemenger M; Levy JB; Brown EA
    Kidney Int Suppl; 2006 Nov; (103):S63-6. PubMed ID: 17080113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonitis in continuous ambulatory peritoneal dialysis: a role for the dialysate?
    Marichal JF; Faller B; Brignon P; Degoulet P; Aime F
    Nephron; 1986; 42(2):167-70. PubMed ID: 3945356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis.
    Thongboonkerd V; Lumlertgul D; Supajatura V
    Artif Organs; 2001 Feb; 25(2):99-108. PubMed ID: 11251475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of a bicarbonate- and a bicarbonate/lactate-containing dialysis solution in CAPD.
    Coles GA; Gokal R; Ogg C; Jani F; O'Donoghue DT; Cancarini GC; Maiorca R; Tranaeus A; Faict D; de Vos C
    Perit Dial Int; 1997; 17(1):48-51. PubMed ID: 9068022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.